Innovent Biologics, Inc.
Innovent Biologics, Inc. is a registered legal entity registered in China, and its current status with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is active. Its registered address on file is Suzhou, China. 5 shareholders are on record for Innovent Biologics, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Innovent Biologics, Inc., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC.
The largest of these is VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund, holding 19.8% — the largest recorded stake — followed by VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd at 18%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 10 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 19.8% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd | 18% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| New World Fund Inc | 11.4% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| Fidelity Investment TRT-Fidelity Series Emerging Markets Opportunities | 4.6% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) | |
| iShares Trust-iShares MSCI China ETF | 3.6% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) |
Officers
5
The Executive Director & Fund Managing Partner of Innovent Biologics, Inc. on record is Hao Xi Ede; 5 officers are shown here, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System).
The register reports 17 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Innovent Biologics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Innovent Biologics, Inc.?
Five shareholders are currently on record for Innovent Biologics, Inc., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund, holding 19.8% — the largest recorded stake — followed by VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd at 18%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Innovent Biologics, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Innovent Biologics, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Innovent Biologics, Inc. have on record?
5 shareholders are shown on record for Innovent Biologics, Inc.. The register reports 10 in total; only the top 5 by holding are shown here.
Is Innovent Biologics, Inc. still an active company?
Innovent Biologics, Inc.'s status on SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is listed as active.
What is Innovent Biologics, Inc.'s registered address?
The registered address on file for Innovent Biologics, Inc. is Suzhou, China.
Who are the officers/directors of Innovent Biologics, Inc.?
The Executive Director & Fund Managing Partner of Innovent Biologics, Inc. on record is Hao Xi Ede; 5 officers are shown here, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Innovent Biologics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Innovent Biologics, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Zavia's monitoring API can track changes to Innovent Biologics, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Innovent Biologics, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including China, so records like Innovent Biologics, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last synced on 22 September 2026.